Global Human Cytomegalovirus Envelope Glycoprotein B Market Growth 2022-2028

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Human Cytomegalovirus Envelope Glycoprotein B Annual Sales 2017-2028

2.1.2 World Current & Future Analysis for Human Cytomegalovirus Envelope Glycoprotein B by Geographic Region, 2017, 2022 & 2028

2.1.3 World Current & Future Analysis for Human Cytomegalovirus Envelope Glycoprotein B by Country/Region, 2017, 2022 & 2028

2.2 Human Cytomegalovirus Envelope Glycoprotein B Segment by Type

2.2.1 CSJ-148

2.2.2 CyMVectin

2.2.3 TRL-345

2.2.4 PPCM

2.2.5 Cytomegalovirus Vaccine

2.2.6 Others

2.3 Human Cytomegalovirus Envelope Glycoprotein B Sales by Type

2.3.1 Global Human Cytomegalovirus Envelope Glycoprotein B Sales Market Share by Type (2017-2022)

2.3.2 Global Human Cytomegalovirus Envelope Glycoprotein B Revenue and Market Share by Type (2017-2022)

2.3.3 Global Human Cytomegalovirus Envelope Glycoprotein B Sale Price by Type (2017-2022)

2.4 Human Cytomegalovirus Envelope Glycoprotein B Segment by Application

2.4.1 Infectious Disease

2.4.2 Oncology

2.4.3 Women's Health

2.4.4 Others

2.5 Human Cytomegalovirus Envelope Glycoprotein B Sales by Application

2.5.1 Global Human Cytomegalovirus Envelope Glycoprotein B Sale Market Share by Application (2017-2022)

2.5.2 Global Human Cytomegalovirus Envelope Glycoprotein B Revenue and Market Share by Application (2017-2022)

2.5.3 Global Human Cytomegalovirus Envelope Glycoprotein B Sale Price by Application (2017-2022)

3 Global Human Cytomegalovirus Envelope Glycoprotein B by Company

3.1 Global Human Cytomegalovirus Envelope Glycoprotein B Breakdown Data by Company

3.1.1 Global Human Cytomegalovirus Envelope Glycoprotein B Annual Sales by Company (2020-2022)

3.1.2 Global Human Cytomegalovirus Envelope Glycoprotein B Sales Market Share by Company (2020-2022)

3.2 Global Human Cytomegalovirus Envelope Glycoprotein B Annual Revenue by Company (2020-2022)

3.2.1 Global Human Cytomegalovirus Envelope Glycoprotein B Revenue by Company (2020-2022)

3.2.2 Global Human Cytomegalovirus Envelope Glycoprotein B Revenue Market Share by Company (2020-2022)

3.3 Global Human Cytomegalovirus Envelope Glycoprotein B Sale Price by Company

3.4 Key Manufacturers Human Cytomegalovirus Envelope Glycoprotein B Producing Area Distribution, Sales Area, Product Type

3.4.1 Key Manufacturers Human Cytomegalovirus Envelope Glycoprotein B Product Location Distribution

3.4.2 Players Human Cytomegalovirus Envelope Glycoprotein B Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 World Historic Review for Human Cytomegalovirus Envelope Glycoprotein B by Geographic Region

4.1 World Historic Human Cytomegalovirus Envelope Glycoprotein B Market Size by Geographic Region (2017-2022)

4.1.1 Global Human Cytomegalovirus Envelope Glycoprotein B Annual Sales by Geographic Region (2017-2022)

4.1.2 Global Human Cytomegalovirus Envelope Glycoprotein B Annual Revenue by Geographic Region

4.2 World Historic Human Cytomegalovirus Envelope Glycoprotein B Market Size by Country/Region (2017-2022)

4.2.1 Global Human Cytomegalovirus Envelope Glycoprotein B Annual Sales by Country/Region (2017-2022)

4.2.2 Global Human Cytomegalovirus Envelope Glycoprotein B Annual Revenue by Country/Region

4.3 Americas Human Cytomegalovirus Envelope Glycoprotein B Sales Growth

4.4 APAC Human Cytomegalovirus Envelope Glycoprotein B Sales Growth

4.5 Europe Human Cytomegalovirus Envelope Glycoprotein B Sales Growth

4.6 Middle East & Africa Human Cytomegalovirus Envelope Glycoprotein B Sales Growth

5 Americas

5.1 Americas Human Cytomegalovirus Envelope Glycoprotein B Sales by Country

5.1.1 Americas Human Cytomegalovirus Envelope Glycoprotein B Sales by Country (2017-2022)

5.1.2 Americas Human Cytomegalovirus Envelope Glycoprotein B Revenue by Country (2017-2022)

5.2 Americas Human Cytomegalovirus Envelope Glycoprotein B Sales by Type

5.3 Americas Human Cytomegalovirus Envelope Glycoprotein B Sales by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Human Cytomegalovirus Envelope Glycoprotein B Sales by Region

6.1.1 APAC Human Cytomegalovirus Envelope Glycoprotein B Sales by Region (2017-2022)

6.1.2 APAC Human Cytomegalovirus Envelope Glycoprotein B Revenue by Region (2017-2022)

6.2 APAC Human Cytomegalovirus Envelope Glycoprotein B Sales by Type

6.3 APAC Human Cytomegalovirus Envelope Glycoprotein B Sales by Application

6.4 China

6.5 Japan

6.6 South Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 China Taiwan

7 Europe

7.1 Europe Human Cytomegalovirus Envelope Glycoprotein B by Country

7.1.1 Europe Human Cytomegalovirus Envelope Glycoprotein B Sales by Country (2017-2022)

7.1.2 Europe Human Cytomegalovirus Envelope Glycoprotein B Revenue by Country (2017-2022)

7.2 Europe Human Cytomegalovirus Envelope Glycoprotein B Sales by Type

7.3 Europe Human Cytomegalovirus Envelope Glycoprotein B Sales by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Human Cytomegalovirus Envelope Glycoprotein B by Country

8.1.1 Middle East & Africa Human Cytomegalovirus Envelope Glycoprotein B Sales by Country (2017-2022)

8.1.2 Middle East & Africa Human Cytomegalovirus Envelope Glycoprotein B Revenue by Country (2017-2022)

8.2 Middle East & Africa Human Cytomegalovirus Envelope Glycoprotein B Sales by Type

8.3 Middle East & Africa Human Cytomegalovirus Envelope Glycoprotein B Sales by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Manufacturing Cost Structure Analysis

10.1 Raw Material and Suppliers

10.2 Manufacturing Cost Structure Analysis of Human Cytomegalovirus Envelope Glycoprotein B

10.3 Manufacturing Process Analysis of Human Cytomegalovirus Envelope Glycoprotein B

10.4 Industry Chain Structure of Human Cytomegalovirus Envelope Glycoprotein B

11 Marketing, Distributors and Customer

11.1 Sales Channel

11.1.1 Direct Channels

11.1.2 Indirect Channels

11.2 Human Cytomegalovirus Envelope Glycoprotein B Distributors

11.3 Human Cytomegalovirus Envelope Glycoprotein B Customer

12 World Forecast Review for Human Cytomegalovirus Envelope Glycoprotein B by Geographic Region

12.1 Global Human Cytomegalovirus Envelope Glycoprotein B Market Size Forecast by Region

12.1.1 Global Human Cytomegalovirus Envelope Glycoprotein B Forecast by Region (2023-2028)

12.1.2 Global Human Cytomegalovirus Envelope Glycoprotein B Annual Revenue Forecast by Region (2023-2028)

12.2 Americas Forecast by Country

12.3 APAC Forecast by Region

12.4 Europe Forecast by Country

12.5 Middle East & Africa Forecast by Country

12.6 Global Human Cytomegalovirus Envelope Glycoprotein B Forecast by Type

12.7 Global Human Cytomegalovirus Envelope Glycoprotein B Forecast by Application

13 Key Players Analysis

13.1 Astellas Pharma Inc.

13.1.1 Astellas Pharma Inc. Company Information

13.1.2 Astellas Pharma Inc. Human Cytomegalovirus Envelope Glycoprotein B Product Offered

13.1.3 Astellas Pharma Inc. Human Cytomegalovirus Envelope Glycoprotein B Sales, Revenue, Price and Gross Margin (2020-2022)

13.1.4 Astellas Pharma Inc. Main Business Overview

13.1.5 Astellas Pharma Inc. Latest Developments

13.2 Trellis Bioscience, Inc.

13.2.1 Trellis Bioscience, Inc. Company Information

13.2.2 Trellis Bioscience, Inc. Human Cytomegalovirus Envelope Glycoprotein B Product Offered

13.2.3 Trellis Bioscience, Inc. Human Cytomegalovirus Envelope Glycoprotein B Sales, Revenue, Price and Gross Margin (2020-2022)

13.2.4 Trellis Bioscience, Inc. Main Business Overview

13.2.5 Trellis Bioscience, Inc. Latest Developments

13.3 Vakzine Projekt Management GmbH

13.3.1 Vakzine Projekt Management GmbH Company Information

13.3.2 Vakzine Projekt Management GmbH Human Cytomegalovirus Envelope Glycoprotein B Product Offered

13.3.3 Vakzine Projekt Management GmbH Human Cytomegalovirus Envelope Glycoprotein B Sales, Revenue, Price and Gross Margin (2020-2022)

13.3.4 Vakzine Projekt Management GmbH Main Business Overview

13.3.5 Vakzine Projekt Management GmbH Latest Developments

13.4 VBI Vaccine Inc

13.4.1 VBI Vaccine Inc Company Information

13.4.2 VBI Vaccine Inc Human Cytomegalovirus Envelope Glycoprotein B Product Offered

13.4.3 VBI Vaccine Inc Human Cytomegalovirus Envelope Glycoprotein B Sales, Revenue, Price and Gross Margin (2020-2022)

13.4.4 VBI Vaccine Inc Main Business Overview

13.4.5 VBI Vaccine Inc Latest Developments

13.5 Vical Incorporated

13.5.1 Vical Incorporated Company Information

13.5.2 Vical Incorporated Human Cytomegalovirus Envelope Glycoprotein B Product Offered

13.5.3 Vical Incorporated Human Cytomegalovirus Envelope Glycoprotein B Sales, Revenue, Price and Gross Margin (2020-2022)

13.5.4 Vical Incorporated Main Business Overview

13.5.5 Vical Incorporated Latest Developments

14 Research Findings and Conclusion

Table 1. Human Cytomegalovirus Envelope Glycoprotein B Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)

Table 2. Human Cytomegalovirus Envelope Glycoprotein B Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)

Table 3. Major Players of CSJ-148

Table 4. Major Players of CyMVectin

Table 5. Major Players of TRL-345

Table 6. Major Players of PPCM

Table 7. Major Players of Cytomegalovirus Vaccine

Table 8. Major Players of Others

Table 9. Global Human Cytomegalovirus Envelope Glycoprotein B Sales by Type (2017-2022) & (K Pcs)

Table 10. Global Human Cytomegalovirus Envelope Glycoprotein B Sales Market Share by Type (2017-2022)

Table 11. Global Human Cytomegalovirus Envelope Glycoprotein B Revenue by Type (2017-2022) & ($ million)

Table 12. Global Human Cytomegalovirus Envelope Glycoprotein B Revenue Market Share by Type (2017-2022)

Table 13. Global Human Cytomegalovirus Envelope Glycoprotein B Sale Price by Type (2017-2022) & (USD/Pcs)

Table 14. Global Human Cytomegalovirus Envelope Glycoprotein B Sales by Application (2017-2022) & (K Pcs)

Table 15. Global Human Cytomegalovirus Envelope Glycoprotein B Sales Market Share by Application (2017-2022)

Table 16. Global Human Cytomegalovirus Envelope Glycoprotein B Revenue by Application (2017-2022)

Table 17. Global Human Cytomegalovirus Envelope Glycoprotein B Revenue Market Share by Application (2017-2022)

Table 18. Global Human Cytomegalovirus Envelope Glycoprotein B Sale Price by Application (2017-2022) & (USD/Pcs)

Table 19. Global Human Cytomegalovirus Envelope Glycoprotein B Sales by Company (2020-2022) & (K Pcs)

Table 20. Global Human Cytomegalovirus Envelope Glycoprotein B Sales Market Share by Company (2020-2022)

Table 21. Global Human Cytomegalovirus Envelope Glycoprotein B Revenue by Company (2020-2022) ($ Millions)

Table 22. Global Human Cytomegalovirus Envelope Glycoprotein B Revenue Market Share by Company (2020-2022)

Table 23. Global Human Cytomegalovirus Envelope Glycoprotein B Sale Price by Company (2020-2022) & (USD/Pcs)

Table 24. Key Manufacturers Human Cytomegalovirus Envelope Glycoprotein B Producing Area Distribution and Sales Area

Table 25. Players Human Cytomegalovirus Envelope Glycoprotein B Products Offered

Table 26. Human Cytomegalovirus Envelope Glycoprotein B Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 27. New Products and Potential Entrants

Table 28. Mergers & Acquisitions, Expansion

Table 29. Global Human Cytomegalovirus Envelope Glycoprotein B Sales by Geographic Region (2017-2022) & (K Pcs)

Table 30. Global Human Cytomegalovirus Envelope Glycoprotein B Sales Market Share Geographic Region (2017-2022)

Table 31. Global Human Cytomegalovirus Envelope Glycoprotein B Revenue by Geographic Region (2017-2022) & ($ millions)

Table 32. Global Human Cytomegalovirus Envelope Glycoprotein B Revenue Market Share by Geographic Region (2017-2022)

Table 33. Global Human Cytomegalovirus Envelope Glycoprotein B Sales by Country/Region (2017-2022) & (K Pcs)

Table 34. Global Human Cytomegalovirus Envelope Glycoprotein B Sales Market Share by Country/Region (2017-2022)

Table 35. Global Human Cytomegalovirus Envelope Glycoprotein B Revenue by Country/Region (2017-2022) & ($ millions)

Table 36. Global Human Cytomegalovirus Envelope Glycoprotein B Revenue Market Share by Country/Region (2017-2022)

Table 37. Americas Human Cytomegalovirus Envelope Glycoprotein B Sales by Country (2017-2022) & (K Pcs)

Table 38. Americas Human Cytomegalovirus Envelope Glycoprotein B Sales Market Share by Country (2017-2022)

Table 39. Americas Human Cytomegalovirus Envelope Glycoprotein B Revenue by Country (2017-2022) & ($ Millions)

Table 40. Americas Human Cytomegalovirus Envelope Glycoprotein B Revenue Market Share by Country (2017-2022)

Table 41. Americas Human Cytomegalovirus Envelope Glycoprotein B Sales by Type (2017-2022) & (K Pcs)

Table 42. Americas Human Cytomegalovirus Envelope Glycoprotein B Sales Market Share by Type (2017-2022)

Table 43. Americas Human Cytomegalovirus Envelope Glycoprotein B Sales by Application (2017-2022) & (K Pcs)

Table 44. Americas Human Cytomegalovirus Envelope Glycoprotein B Sales Market Share by Application (2017-2022)

Table 45. APAC Human Cytomegalovirus Envelope Glycoprotein B Sales by Region (2017-2022) & (K Pcs)

Table 46. APAC Human Cytomegalovirus Envelope Glycoprotein B Sales Market Share by Region (2017-2022)

Table 47. APAC Human Cytomegalovirus Envelope Glycoprotein B Revenue by Region (2017-2022) & ($ Millions)

Table 48. APAC Human Cytomegalovirus Envelope Glycoprotein B Revenue Market Share by Region (2017-2022)

Table 49. APAC Human Cytomegalovirus Envelope Glycoprotein B Sales by Type (2017-2022) & (K Pcs)

Table 50. APAC Human Cytomegalovirus Envelope Glycoprotein B Sales Market Share by Type (2017-2022)

Table 51. APAC Human Cytomegalovirus Envelope Glycoprotein B Sales by Application (2017-2022) & (K Pcs)

Table 52. APAC Human Cytomegalovirus Envelope Glycoprotein B Sales Market Share by Application (2017-2022)

Table 53. Europe Human Cytomegalovirus Envelope Glycoprotein B Sales by Country (2017-2022) & (K Pcs)

Table 54. Europe Human Cytomegalovirus Envelope Glycoprotein B Sales Market Share by Country (2017-2022)

Table 55. Europe Human Cytomegalovirus Envelope Glycoprotein B Revenue by Country (2017-2022) & ($ Millions)

Table 56. Europe Human Cytomegalovirus Envelope Glycoprotein B Revenue Market Share by Country (2017-2022)

Table 57. Europe Human Cytomegalovirus Envelope Glycoprotein B Sales by Type (2017-2022) & (K Pcs)

Table 58. Europe Human Cytomegalovirus Envelope Glycoprotein B Sales Market Share by Type (2017-2022)

Table 59. Europe Human Cytomegalovirus Envelope Glycoprotein B Sales by Application (2017-2022) & (K Pcs)

Table 60. Europe Human Cytomegalovirus Envelope Glycoprotein B Sales Market Share by Application (2017-2022)

Table 61. Middle East & Africa Human Cytomegalovirus Envelope Glycoprotein B Sales by Country (2017-2022) & (K Pcs)

Table 62. Middle East & Africa Human Cytomegalovirus Envelope Glycoprotein B Sales Market Share by Country (2017-2022)

Table 63. Middle East & Africa Human Cytomegalovirus Envelope Glycoprotein B Revenue by Country (2017-2022) & ($ Millions)

Table 64. Middle East & Africa Human Cytomegalovirus Envelope Glycoprotein B Revenue Market Share by Country (2017-2022)

Table 65. Middle East & Africa Human Cytomegalovirus Envelope Glycoprotein B Sales by Type (2017-2022) & (K Pcs)

Table 66. Middle East & Africa Human Cytomegalovirus Envelope Glycoprotein B Sales Market Share by Type (2017-2022)

Table 67. Middle East & Africa Human Cytomegalovirus Envelope Glycoprotein B Sales by Application (2017-2022) & (K Pcs)

Table 68. Middle East & Africa Human Cytomegalovirus Envelope Glycoprotein B Sales Market Share by Application (2017-2022)

Table 69. Key Market Drivers & Growth Opportunities of Human Cytomegalovirus Envelope Glycoprotein B

Table 70. Key Market Challenges & Risks of Human Cytomegalovirus Envelope Glycoprotein B

Table 71. Key Industry Trends of Human Cytomegalovirus Envelope Glycoprotein B

Table 72. Human Cytomegalovirus Envelope Glycoprotein B Raw Material

Table 73. Key Suppliers of Raw Materials

Table 74. Human Cytomegalovirus Envelope Glycoprotein B Distributors List

Table 75. Human Cytomegalovirus Envelope Glycoprotein B Customer List

Table 76. Global Human Cytomegalovirus Envelope Glycoprotein B Sales Forecast by Region (2023-2028) & (K Pcs)

Table 77. Global Human Cytomegalovirus Envelope Glycoprotein B Sales Market Forecast by Region

Table 78. Global Human Cytomegalovirus Envelope Glycoprotein B Revenue Forecast by Region (2023-2028) & ($ millions)

Table 79. Global Human Cytomegalovirus Envelope Glycoprotein B Revenue Market Share Forecast by Region (2023-2028)

Table 80. Americas Human Cytomegalovirus Envelope Glycoprotein B Sales Forecast by Country (2023-2028) & (K Pcs)

Table 81. Americas Human Cytomegalovirus Envelope Glycoprotein B Revenue Forecast by Country (2023-2028) & ($ millions)

Table 82. APAC Human Cytomegalovirus Envelope Glycoprotein B Sales Forecast by Region (2023-2028) & (K Pcs)

Table 83. APAC Human Cytomegalovirus Envelope Glycoprotein B Revenue Forecast by Region (2023-2028) & ($ millions)

Table 84. Europe Human Cytomegalovirus Envelope Glycoprotein B Sales Forecast by Country (2023-2028) & (K Pcs)

Table 85. Europe Human Cytomegalovirus Envelope Glycoprotein B Revenue Forecast by Country (2023-2028) & ($ millions)

Table 86. Middle East & Africa Human Cytomegalovirus Envelope Glycoprotein B Sales Forecast by Country (2023-2028) & (K Pcs)

Table 87. Middle East & Africa Human Cytomegalovirus Envelope Glycoprotein B Revenue Forecast by Country (2023-2028) & ($ millions)

Table 88. Global Human Cytomegalovirus Envelope Glycoprotein B Sales Forecast by Type (2023-2028) & (K Pcs)

Table 89. Global Human Cytomegalovirus Envelope Glycoprotein B Sales Market Share Forecast by Type (2023-2028)

Table 90. Global Human Cytomegalovirus Envelope Glycoprotein B Revenue Forecast by Type (2023-2028) & ($ Millions)

Table 91. Global Human Cytomegalovirus Envelope Glycoprotein B Revenue Market Share Forecast by Type (2023-2028)

Table 92. Global Human Cytomegalovirus Envelope Glycoprotein B Sales Forecast by Application (2023-2028) & (K Pcs)

Table 93. Global Human Cytomegalovirus Envelope Glycoprotein B Sales Market Share Forecast by Application (2023-2028)

Table 94. Global Human Cytomegalovirus Envelope Glycoprotein B Revenue Forecast by Application (2023-2028) & ($ Millions)

Table 95. Global Human Cytomegalovirus Envelope Glycoprotein B Revenue Market Share Forecast by Application (2023-2028)

Table 96. Astellas Pharma Inc. Basic Information, Human Cytomegalovirus Envelope Glycoprotein B Manufacturing Base, Sales Area and Its Competitors

Table 97. Astellas Pharma Inc. Human Cytomegalovirus Envelope Glycoprotein B Product Offered

Table 98. Astellas Pharma Inc. Human Cytomegalovirus Envelope Glycoprotein B Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 99. Astellas Pharma Inc. Main Business

Table 100. Astellas Pharma Inc. Latest Developments

Table 101. Trellis Bioscience, Inc. Basic Information, Human Cytomegalovirus Envelope Glycoprotein B Manufacturing Base, Sales Area and Its Competitors

Table 102. Trellis Bioscience, Inc. Human Cytomegalovirus Envelope Glycoprotein B Product Offered

Table 103. Trellis Bioscience, Inc. Human Cytomegalovirus Envelope Glycoprotein B Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 104. Trellis Bioscience, Inc. Main Business

Table 105. Trellis Bioscience, Inc. Latest Developments

Table 106. Vakzine Projekt Management GmbH Basic Information, Human Cytomegalovirus Envelope Glycoprotein B Manufacturing Base, Sales Area and Its Competitors

Table 107. Vakzine Projekt Management GmbH Human Cytomegalovirus Envelope Glycoprotein B Product Offered

Table 108. Vakzine Projekt Management GmbH Human Cytomegalovirus Envelope Glycoprotein B Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 109. Vakzine Projekt Management GmbH Main Business

Table 110. Vakzine Projekt Management GmbH Latest Developments

Table 111. VBI Vaccine Inc Basic Information, Human Cytomegalovirus Envelope Glycoprotein B Manufacturing Base, Sales Area and Its Competitors

Table 112. VBI Vaccine Inc Human Cytomegalovirus Envelope Glycoprotein B Product Offered

Table 113. VBI Vaccine Inc Human Cytomegalovirus Envelope Glycoprotein B Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 114. VBI Vaccine Inc Main Business

Table 115. VBI Vaccine Inc Latest Developments

Table 116. Vical Incorporated Basic Information, Human Cytomegalovirus Envelope Glycoprotein B Manufacturing Base, Sales Area and Its Competitors

Table 117. Vical Incorporated Human Cytomegalovirus Envelope Glycoprotein B Product Offered

Table 118. Vical Incorporated Human Cytomegalovirus Envelope Glycoprotein B Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 119. Vical Incorporated Main Business

Table 120. Vical Incorporated Latest Developments

List of Figures

Figure 1. Picture of Human Cytomegalovirus Envelope Glycoprotein B

Figure 2. Human Cytomegalovirus Envelope Glycoprotein B Report Years Considered

Figure 3. Research Objectives

Figure 4. Research Methodology

Figure 5. Research Process and Data Source

Figure 6. Global Human Cytomegalovirus Envelope Glycoprotein B Sales Growth Rate 2017-2028 (K Pcs)

Figure 7. Global Human Cytomegalovirus Envelope Glycoprotein B Revenue Growth Rate 2017-2028 ($ Millions)

Figure 8. Human Cytomegalovirus Envelope Glycoprotein B Sales by Region (2021 & 2028) & ($ millions)

Figure 9. Product Picture of CSJ-148

Figure 10. Product Picture of CyMVectin

Figure 11. Product Picture of TRL-345

Figure 12. Product Picture of PPCM

Figure 13. Product Picture of Cytomegalovirus Vaccine

Figure 14. Product Picture of Others

Figure 15. Global Human Cytomegalovirus Envelope Glycoprotein B Sales Market Share by Type in 2021

Figure 16. Global Human Cytomegalovirus Envelope Glycoprotein B Revenue Market Share by Type (2017-2022)

Figure 17. Human Cytomegalovirus Envelope Glycoprotein B Consumed in Infectious Disease

Figure 18. Global Human Cytomegalovirus Envelope Glycoprotein B Market: Infectious Disease (2017-2022) & (K Pcs)

Figure 19. Human Cytomegalovirus Envelope Glycoprotein B Consumed in Oncology

Figure 20. Global Human Cytomegalovirus Envelope Glycoprotein B Market: Oncology (2017-2022) & (K Pcs)

Figure 21. Human Cytomegalovirus Envelope Glycoprotein B Consumed in Women's Health

Figure 22. Global Human Cytomegalovirus Envelope Glycoprotein B Market: Women's Health (2017-2022) & (K Pcs)

Figure 23. Human Cytomegalovirus Envelope Glycoprotein B Consumed in Others

Figure 24. Global Human Cytomegalovirus Envelope Glycoprotein B Market: Others (2017-2022) & (K Pcs)

Figure 25. Global Human Cytomegalovirus Envelope Glycoprotein B Sales Market Share by Application (2017-2022)

Figure 26. Global Human Cytomegalovirus Envelope Glycoprotein B Revenue Market Share by Application in 2021

Figure 27. Human Cytomegalovirus Envelope Glycoprotein B Revenue Market by Company in 2021 ($ Million)

Figure 28. Global Human Cytomegalovirus Envelope Glycoprotein B Revenue Market Share by Company in 2021

Figure 29. Global Human Cytomegalovirus Envelope Glycoprotein B Sales Market Share by Geographic Region (2017-2022)

Figure 30. Global Human Cytomegalovirus Envelope Glycoprotein B Revenue Market Share by Geographic Region in 2021

Figure 31. Global Human Cytomegalovirus Envelope Glycoprotein B Sales Market Share by Region (2017-2022)

Figure 32. Global Human Cytomegalovirus Envelope Glycoprotein B Revenue Market Share by Country/Region in 2021

Figure 33. Americas Human Cytomegalovirus Envelope Glycoprotein B Sales 2017-2022 (K Pcs)

Figure 34. Americas Human Cytomegalovirus Envelope Glycoprotein B Revenue 2017-2022 ($ Millions)

Figure 35. APAC Human Cytomegalovirus Envelope Glycoprotein B Sales 2017-2022 (K Pcs)

Figure 36. APAC Human Cytomegalovirus Envelope Glycoprotein B Revenue 2017-2022 ($ Millions)

Figure 37. Europe Human Cytomegalovirus Envelope Glycoprotein B Sales 2017-2022 (K Pcs)

Figure 38. Europe Human Cytomegalovirus Envelope Glycoprotein B Revenue 2017-2022 ($ Millions)

Figure 39. Middle East & Africa Human Cytomegalovirus Envelope Glycoprotein B Sales 2017-2022 (K Pcs)

Figure 40. Middle East & Africa Human Cytomegalovirus Envelope Glycoprotein B Revenue 2017-2022 ($ Millions)

Figure 41. Americas Human Cytomegalovirus Envelope Glycoprotein B Sales Market Share by Country in 2021

Figure 42. Americas Human Cytomegalovirus Envelope Glycoprotein B Revenue Market Share by Country in 2021

Figure 43. United States Human Cytomegalovirus Envelope Glycoprotein B Revenue Growth 2017-2022 ($ Millions)

Figure 44. Canada Human Cytomegalovirus Envelope Glycoprotein B Revenue Growth 2017-2022 ($ Millions)

Figure 45. Mexico Human Cytomegalovirus Envelope Glycoprotein B Revenue Growth 2017-2022 ($ Millions)

Figure 46. Brazil Human Cytomegalovirus Envelope Glycoprotein B Revenue Growth 2017-2022 ($ Millions)

Figure 47. APAC Human Cytomegalovirus Envelope Glycoprotein B Sales Market Share by Region in 2021

Figure 48. APAC Human Cytomegalovirus Envelope Glycoprotein B Revenue Market Share by Regions in 2021

Figure 49. China Human Cytomegalovirus Envelope Glycoprotein B Revenue Growth 2017-2022 ($ Millions)

Figure 50. Japan Human Cytomegalovirus Envelope Glycoprotein B Revenue Growth 2017-2022 ($ Millions)

Figure 51. South Korea Human Cytomegalovirus Envelope Glycoprotein B Revenue Growth 2017-2022 ($ Millions)

Figure 52. Southeast Asia Human Cytomegalovirus Envelope Glycoprotein B Revenue Growth 2017-2022 ($ Millions)

Figure 53. India Human Cytomegalovirus Envelope Glycoprotein B Revenue Growth 2017-2022 ($ Millions)

Figure 54. Australia Human Cytomegalovirus Envelope Glycoprotein B Revenue Growth 2017-2022 ($ Millions)

Figure 55. Europe Human Cytomegalovirus Envelope Glycoprotein B Sales Market Share by Country in 2021

Figure 56. Europe Human Cytomegalovirus Envelope Glycoprotein B Revenue Market Share by Country in 2021

Figure 57. Germany Human Cytomegalovirus Envelope Glycoprotein B Revenue Growth 2017-2022 ($ Millions)

Figure 58. France Human Cytomegalovirus Envelope Glycoprotein B Revenue Growth 2017-2022 ($ Millions)

Figure 59. UK Human Cytomegalovirus Envelope Glycoprotein B Revenue Growth 2017-2022 ($ Millions)

Figure 60. Italy Human Cytomegalovirus Envelope Glycoprotein B Revenue Growth 2017-2022 ($ Millions)

Figure 61. Russia Human Cytomegalovirus Envelope Glycoprotein B Revenue Growth 2017-2022 ($ Millions)

Figure 62. Middle East & Africa Human Cytomegalovirus Envelope Glycoprotein B Sales Market Share by Country in 2021

Figure 63. Middle East & Africa Human Cytomegalovirus Envelope Glycoprotein B Revenue Market Share by Country in 2021

Figure 64. Egypt Human Cytomegalovirus Envelope Glycoprotein B Revenue Growth 2017-2022 ($ Millions)

Figure 65. South Africa Human Cytomegalovirus Envelope Glycoprotein B Revenue Growth 2017-2022 ($ Millions)

Figure 66. Israel Human Cytomegalovirus Envelope Glycoprotein B Revenue Growth 2017-2022 ($ Millions)

Figure 67. Turkey Human Cytomegalovirus Envelope Glycoprotein B Revenue Growth 2017-2022 ($ Millions)

Figure 68. GCC Country Human Cytomegalovirus Envelope Glycoprotein B Revenue Growth 2017-2022 ($ Millions)

Figure 69. Manufacturing Cost Structure Analysis of Human Cytomegalovirus Envelope Glycoprotein B in 2021

Figure 70. Manufacturing Process Analysis of Human Cytomegalovirus Envelope Glycoprotein B

Figure 71. Industry Chain Structure of Human Cytomegalovirus Envelope Glycoprotein B

Figure 72. Channels of Distribution

Figure 73. Distributors Profiles